Zealand Pharma A/S
  • About Zealand
    • About Us
    • Disease Focus
    • History
    • Corporate Management
    • Corporate Governance
    • Corporate Social Responsibility
    • Board of Directors
    • Videos About Zealand
    • Transparency Reporting
  • R&D
    • Our Focus
    • Product Pipeline
    • Glepaglutide for SBS
    • Dasiglucagon for BHAP Systems
    • Dasiglucagon for CHI
    • BI 456906 GLP-1/GLU Dual Agonist
    • Amylin Analogue, ZP8396
    • In-licensing
    • What are Peptides?
    • Peptide Platform Video
  • Investor
    • Investor Relations
    • Corporate Presentation
    • Stock Information
    • Shareholder Portal
    • Financial Calendar
    • Financial Reports
    • Events
    • Annual General Meeting
    • SEC Filings
    • Analyst Coverage
    • Prospectus
  • Media
    • Zealand News
    • Media Inquiry
    • Downloads
  • Careers
    • Zealand as a Workplace
    • Meet Us
    • Positions
    • Personal Data in the Recruitment Process
    • Disclaimer: Beware of Recruitment Fraud
  • Contact

Pages

  • About Zealand
    • About Us
    • Board of Directors
    • Corporate Governance
      • Audit Committee
      • Nomination Committee
      • Remuneration Committee
      • Scientific Committee
    • Corporate Management
    • Corporate Social Responsibility
    • Disease Focus
      • Gastrointestinal (GI) Diseases
        • Marianne’s Story
        • Mike’s Story
        • Will’s Story
      • Metabolic Diseases
        • Crosby’s Story
    • History
    • Strategy
    • Transparency Reporting
    • Videos About Zealand
  • Careers
    • Disclaimer: Beware of Recruitment Fraud
    • Meet Us
    • Personal Data in the Recruitment Process
    • Positions
    • Zealand as a Workplace
  • Contact
  • Home
  • Investor
    • Analyst Coverage
    • Annual General Meeting
    • Corporate Presentation
    • Corporate Presentation (PDF)
    • Events
    • Financial Calendar
    • Financial Reports
      • Financial Reports for 2014
      • Financial Reports for 2015
      • Financial Reports for 2016
      • Financial Reports for 2017
      • Financial Reports for 2018
      • Financial Reports for 2019
      • Financial Reports for 2020
      • Financial Reports for 2021
      • Financial Reports for 2022
    • Investor Relations
    • Newsletter Signup
    • Prospectus
    • SEC Filings
    • Shareholder Portal
    • Stock Information
  • Legal Disclaimer
  • Media
    • Downloads
    • Media Inquiry
    • Zealand News
  • Privacy Policy
  • R&D
    • Amylin Analogue, ZP8396 for Obesity
    • BI 456906 GLP-1/Glucagon Dual Agonist (obesity, NASH, diabetes)
    • Dasiglucagon for Bi-Hormonal Artificial Pancreas Systems
    • Dasiglucagon for Congenital Hyperinsulinism
    • Glepaglutide for Short Bowel Syndrome
    • In-licensing
    • Our Focus on Peptide-Based Medicines
    • Peptide Platform Video
    • Product Pipeline
    • What are Peptides

Zealand Pharma A/S     Sydmarken 11      2860 Søborg Denmark     Tel +45 88 77 36 00     info@zealandpharma.com

Legal disclaimer     Privacy policy